CURX (Curanex Pharmaceuticals Inc Common Stock) Stock Analysis - Insider Trades

Curanex Pharmaceuticals Inc Common Stock (CURX) is a publicly traded the market company. As of May 21, 2026, CURX trades at $0.33 with a market cap of $8.53M and a P/E ratio of -1.91. CURX moved +0.00% today. Year to date, CURX is -9.92%; over the trailing twelve months it is flat. Its 52-week range spans $0.26 to $9.18. Rallies surfaces CURX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CURX stock inside the company?

Rallies tracks CURX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

CURX Key Metrics

Key financial metrics for CURX
MetricValue
Price$0.33
Market Cap$8.53M
P/E Ratio-1.91
EPS$-0.17
Dividend Yield0.00%
52-Week High$9.18
52-Week Low$0.26
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-4.23M
Gross Margin0.00%

Latest CURX News

CURX Analyst Consensus

CURX analyst coverage data. Average price target: $0.00.

Common questions about CURX

Who is trading CURX stock inside the company?
Rallies tracks CURX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for CURX?
Yes. Rallies tracks CURX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CURX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CURX. It does not provide personalized investment advice.
CURX

CURX